Table 5.

Association between MDRD eGFR and cardiac neuropathy complication risk score

Adjustment	Race / Ethnicity	T2D status	Estimate	SE	P-value
None	AA	Control	−2.62	1.52	0.09
None	AA	Case	−5.77	1.43	5.2E-05
None	EA	Control	−4.79	1.71	6.6E-03
None	EA	Case	−6.74	1.65	4.3E-05
Age and gender	AA	Control	0.05	1.87	0.98
Age and gender	AA	Case	−3.90	1.62	0.02
Age and gender	EA	Control	−0.87	2.43	0.72
Age and gender	EA	Case	−2.82	1.92	0.14
Age, gender and BMI	AA	Control	0.98	2.57	0.70
Age, gender and BMI	AA	Case	−4.43	2.69	0.10
Age, gender and BMI	EA	Control	−0.91	4.61	0.84
Age, gender and BMI	EA	Case	−2.28	3.24	0.48
Age, gender, BMI and HbA1c	AA	Control	0.94	2.57	0.71
Age, gender, BMI and HbA1c	AA	Case	−4.77	2.70	0.08
Age, gender, BMI and HbA1c	EA	Control	1.01	4.67	0.83
Age, gender, BMI and HbA1c	EA	Case	−2.29	3.25	0.48

T2D – type 2 diabetes; SE – standard error; AA – African American; EA – European American; BMI – body mass index; HbA1c – hemoglobin A1c